Pfizer RSV vaccine 82% effective vs severe infection in infants, final data showed
On Apr. 5, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
-
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Therapeutics | Vaccine
Frequent testing reduced COVID-19 deaths in nursing facilities
On Apr. 4, 2023, National Institutes of Health (NIH) funded research was announced from the University of Rochester…
-
NanoViricides announced licensing agreement with Karveer Meditech to commercialize COVID drugs
On Apr. 4, 2023, NanoViricides announced that it had executed a license agreement with Karveer Meditech, Kolhapur, India,…
-
Biotechnology | Diagnostics | Medicine | NIH | Oncology | Radiology | Therapeutics | Women's Health
U.S. Department of Health and Human Services released National Cancer Plan
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
-
Extremely rare gene variants point to a potential cause of age-related macular degeneration
On Apr. 3, 2023, a study from the National Eye Institute (NEI) identified rare genetic variants that could…
-
First case of highly pathogenic Avian influenza confirmed in Klamath County
On Mar. 31, 2023, the Oregon Department of Agriculture and the United States Department of Agriculture’s Animal and…
-
Moderna finalized agreement with Government of the Republic of Kenya to establish an mRNA manufacturing facility
On Mar. 30, 2023, Moderna and the Government of the Republic of Kenya announced they had finalized an…
-
Biotechnology | Diagnostics | Disease | Vaccine | WHO
WHO certified Azerbaijan and Tajikistan as malaria-free
On Mar. 29, 2023, the World Health Organization (WHO) announced that it had certified Azerbaijan and Tajikistan for…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Vaccine
Covid-19 pandemic and the expansion of the mortality gap between the U.S. and its European peers
On Mar. 29, 2023, the mortality gap between the United States and other high-income nations substantially expanded during…
-
U.S. FDA approved first Over-the-Counter Naloxone nasal spray
On Mar. 29, 2023, the U.S. Food and Drug Administration (FDA) announced approval of Narcan, 4 milligram naloxone…
-
The Priestley Medal was awarded to Cato T. Laurencin
On Mar. 28, 2023, the American Chemical Society awarded The Priestley Medal to Cato T. Laurencin “to recognize distinguished…
-
Thermo Fisher Scientific opened cell therapy facility at University of California, San Francisco
On Mar. 27. 2023, Thermo Fisher Scientific and the University of California, San Francisco, announced they will accelerate…
-
CIRM invested $26 million in research
On Mar. 27, 2023, California Institute for Regenerative Medicine (CIRM) Board approved investing nearly $26 million in 17…
-
Human infection with Avian influenza A(H3N8) virus reported by China
On Mar. 27, 2023, the National Health Commission of the People’s Republic of China reported a confirmed case…
-
Guangdong CDC reported an H3N8 infection
On Mar. 26,. 2023, Guangdong Centers for Disease Control in China reported an H3N8 infection that would become…
-
Biotechnology | CDC | COVID-19 | Diagnostics | Vaccine
Tuberculosis in the U.S. increased slightly during 2022 although it remained lower than prepandemic years
On Mar. 24, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Tuberculosis (TB) in…
-
Antibiotics do not cut death risk in hospitalized patients with viral respiratory illnesses
On Mar. 24. 2023, antibiotics do not reduce the risk of dying in adults hospitalized with COVID-19, the…
-
Paxlovid reduced risk of long-term health problems, death from COVID-19
On Mar. 23. 2023, researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs…
-
Hutchinson Cancer Center announced new “patient-centric” building in South Lake Union
On Mar. 23, 2023, the Fred Hutchinson Cancer Center (FHCRC) announced a new building in South Lake Union…
-
Faba bean genome sequenced, 4X larger Than Human
On Mar. 23. 2023, scientists at the National Research Institute for Agriculture, Food and the Environment in Paris…
-
Climate warming and increasing Vibrio vulnificus infections in North America
On Mar. 23, 2023, a study published in Scientific Reports warned that vibrio vulnificus is an increasingly recognized…
-
Scientists sequenced Beethoven’s genome from locks of his hair
On Mar. 22. 2023, scientists at the University of Cambridge announced that Beethovenﾒs genome had been sequenced for…
-
National Science Foundation released reports outlining bold goals for U.S. bioeconomy
On Mar. 22, 2023, the White House Office of Science and Technology Policy released a series of five…
-
Quest Diagnostics announced first-of-its-kind post-COVID-19 panels available
On Mar. 21, 2023, Quest Diagnostics announced that it had introduced two innovative Post-COVID-19 panels. These laboratory tests…
-
CDC acquired 465-acre site in Mace, West Virginia for research facility
On Mar. 21, 2023, the Centers for Disease Control and Prevention announced the acquisition of a site in…
-
Tanzania declared an outbreak of Marburg virus disease
On Mar. 21, 2023, the Ministry of Health of the United Republic of Tanzania declared an outbreak of…
-
Biology | CDC | Disease | Non-Profit Research | Therapeutics
CDC reported increasing threat of spread of antimicrobial-resistant fungus in healthcare facilities
On Mar. 20, 2023, the Centers for Disease Control and Prevention (CDC) reported that Candida auris (C. auris),…
-
Vaccine makers prep bird flu shot for humans ‘just in case’, rich nations lock in supplies
On Mar. 20, 2023, some of the world’s leading makers of flu vaccines said they could make hundreds…
-
Biotechnology | COVID-19 | NIH | Pharmaceutical | Vaccine
SARS-CoV-2 infection weakens immune-cell response to vaccination
On Mar. 20, 2023, National Institutes of Health (NIH) scientists announced that the magnitude and quality of a…
-
Federal investment to increase Canada’s capacity to develop and manufacture critical medicines
On Mar. 17, 2023, PrairiesCan announced $80,514,000 over five years to support the Canadian Critical Drug Initiative and…
